Event Details

XBiotech Inc at the 26th EADV Congress

Thursday, September 14, 2017 2:00 p.m. CET  
Title
XBiotech Inc at the 26th EADV Congress
Date / Time
09/14/17 2:00 p.m. CET
Location
Geneva, Switzerland  
Description
Results of the Randomized Phase 2 Study Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa will be presented.